Clinical and genetic issues in dilated cardiomyopathy: A review for genetics professionals

Genetics in Medicine

Volumn 12, Issue 11, 2010, Pages 655-667

  Hershberger, Ray E ^a   Morales, Ana ^a   Siegfried, Jill D ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

dilated cardiomyopathy; genetic counseling; genetic testing; genetics

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; ANTHRACYCLINE; COCAINE; DOXORUBICIN; MITOCHONDRIAL DNA; TOXIN; TRASTUZUMAB;

ALLELE; AUTOSOME; CONGESTIVE CARDIOMYOPATHY; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DISEASE TRANSMISSION; DNA STRUCTURE; EPIGENETICS; FAMILIAL DISEASE; GENE DELETION; GENE INSERTION; GENE LOCUS; GENE MUTATION; GENETIC ANALYSIS; GENETIC SCREENING; GENOTYPE; HEALTH CARE PERSONNEL; HEART ARRHYTHMIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; MORBIDITY; MORTALITY; NOMENCLATURE; NONSENSE MUTATION; RESTRICTIVE CARDIOMYOPATHY; REVIEW; SYSTOLIC DYSFUNCTION;

AGE OF ONSET; CARDIOMYOPATHY, DILATED; GENES; GENETIC COUNSELING; GENETIC TESTING; HUMANS; PEDIGREE;

EID: 78649631986     PISSN: 10983600     EISSN: None     Source Type: Journal    
DOI: 10.1097/GIM.0b013e3181f2481f     Document Type: Review

References (131)

1. Hershberger RE. Cardiovascular genetic medicine: evolving concepts, rationale and implementation. J Cardiovasc Trans Res 2008;1:137-143.
2. Lloyd-Jones D, Adams RJ, Brown TM, et al. Heart disease and stroke statistics\2010 update. A report from the American Heart Association. Circulation 2010;121:e46-e215.
3. Hershberger RE. A glimpse into multigene rare variant genetics: triple mutations in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;55: 1454-1455.
4. Burkett EL, Hershberger RE. Clinical and genetic issues in familial dilated cardiomyopathy. J Am Coll Cardiol 2005;45:969-981.
5. Mestroni L, Maisch B, McKenna W, et al. Guidelines for the study of familial dilated cardiomyopathies. Eur Heart J 1999;20:93-102.
6. Dec G, Fuster V. Idiopathic dilated cardiomyopathy. N Engl J Med 1994; 331:1564-1575.
7. Manolio TA, Baughman KL, Rodeheffer R, et al. Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung, and Blood Institute workshop [see comments]). Am J Cardiol 1992;69: 1458-1466.
8. Taylor MR, Carniel E, Mestroni L. Cardiomyopathy, familial dilated. Orphanet J Rare Dis 2006;1:27.
9. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287:1308-1320.
10. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2003;42:1687-1713.
11. Hershberger RE, Cowan J, Morales A, Siegfried JD. Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertro-phic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circ Heart Fail 2009;2:253-261.
12. Cirino AL, Ho C. Familial hypertrophic cardiomyopathy overview. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online), 2008. Available at: http://www.genetests.org. Accessed August 16, 2010.
13. Hershberger R, Norton N, Morales A, et al. Coding sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1 And TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardio-vasc Genet 2010;3:155-161.
14. Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy\a Heart Failure Society of America practice guideline. J Card Fail 2009;15:83-97.
15. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-752.
16. Mayosa B, Khogali S, Zhang B, Watkins H. Cardiac and skeletal actin gene mutations are not a common cause of dilated cardiomyopathy. J Med Genet 1999;36:796-797.
17. Takai E, Akita H, Shiga N, et al. Mutational analysis of the cardiac actin gene in familial and sporadic dilated cardiomyopathy. Am J Med Genet 1999;86:325-327.
18. Tesson F, Sylvius N, Pilotto A, et al. Epidemiology of desmin and cardiac actin gene mutations in a european population of dilated cardiomyopathy [In Process Citation]. Eur Heart J 2000;21:1872-1876.
19. Zolty R, Brodsky G, Perryman B, Bristow M, Mestroni L. Epidemiology of cardiac actin gene mutations in dilated cardiomyopathy. J Card Fail 1999;5:(suppl 1):23.
20. Taylor MR, Slavov D, Ku L, et al. Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 2007;115:1244-1251.
21. Li D, Tapscoft T, Gonzalez O, et al. Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 1999;100:461-464.
22. Karkkainen S, Miettinen R, Tuomainen P, et al. A novel mutation, Arg71Thr, in the delta-sarcoglycan gene is associated with dilated cardio-myopathy. J Mol Med 2003;81:795-800.
23. Tsubata S, Bowles KR, Vatta M, et al. Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy. J Clin Invest 2000;106:655-662.
24. Sylvius N, Duboscq-Bidot L, Bouchier C, et al. Mutational analysis of the beta-and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathy. Am J Med Genet 2003;120A:8-12.
25. Hershberger RE, Parks SB, Kushner JD, et al. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy. Clin Transl Sci 2008;1:21-26.
26. Kamisago M, Sharma SD, DePalma SR, et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. N Engl J Med 2000; 343:1688-1696.
27. Villard E, Duboscq-Bidot L, Charron P, et al. Mutation screening in dilated cardiomyopathy: prominent role of the beta myosin heavy chain gene. Eur Heart J 2005;26:794-803.
28. Daehmlow S, Erdmann J, Knueppel T, et al. Novel mutations in sarcomeric protein genes in dilated cardiomyopathy. Biochem Biophys Res Commun 2002;298:116-120.
29. Hanson E, Jakobs P, Keegan H, et al. Cardiac troponin T lysine-210 deletion in a family with dilated cardiomyopathy. J Card Fail 2002;8:28-32.
30. Mogensen J, Murphy RT, Shaw T, et al. Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 2004;44:2033-2040.
31. Li D, Czernuszewicz GZ, Gonzalez O, et al. Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy. Circulation 2001; 104:2188-2193.
32. Moller DV, Andersen PS, Hedley P, et al. The role of sarcomere gene mutations in patients with idiopathic dilated cardiomyopathy. Eur J Hum Genet 2009;17:1241-1249.
33. Olson TM, Kishimoto NY, Whitby FG, Michels VV. Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated car-diomyopathy. J Mol Cell Cardiol 2001;33:723-732.
34. Lakdawala NK, Dellefave L, Redwood CS, et al. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarco-meric dilated cardiomyopathy. J Am Coll Cardiol 2010;55:320-329.
35. Gerull B, Gramlich M, Atherton J, et al. Mutations of TTN, encoding the giant muscle filament titin, cause familial dilated cardiomyopathy. Nat Genet 2002;14:14.
36. Olson TM, Illenberger S, Kishimoto NY, et al. Metavinculin mutations alter actin interaction in dilated cardiomyopathy. Circulation 2002;105: 431-437.
37. Knoll R, Hoshijima M, Hoffman HM, et al. The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy. Cell 2002;111:943-955.
38. Mohapatra B, Jimenez S, Lin JH, et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocar-dial fibroelastosis. Mol Genet Metab 2003;80:207-215.
39. Schmitt JP, Kamisago M, Asahi M, et al. Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban. Science 2003;299:1410-1413.
40. Haghighi K, Kolokathis F, Pater L, et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. J Clin Invest 2003;111:869-876.
41. Vatta M, Mohapatra B, Jimenez S, et al. Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction. J Am Coll Cardiol 2003;42:2014-2027.
42. Carniel E, Taylor MR, Sinagra G, et al. Alpha-myosin heavy chain: a sarcomeric gene associated with dilated and hypertrophic phenotypes of cardiomyopathy. Circulation 2005;112:54-59.
43. Bienengraeber M, Olson TM, Selivanov VA, et al. ABCC9 mutations identified in human dilated cardiomyopathy disrupt catalytic KATP channel gating. Nat Genet 2004;36:382-387.
44. Hayashi T, Arimura T, Itoh-Satoh M, et al. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy. J Am Coll Car-diol 2004;44:2192-2201.
45. Murphy RT, Mogensen J, Shaw A, et al. Novel mutation in cardiac troponin I in recessive idiopathic dilated cardiomyopathy. Lancet 2004; 363:371-372.
46. Schonberger J, Wang L, Shin JT, et al. Mutation in the transcriptional coactivator EYA4 causes dilated cardiomyopathy and sensorineural hearing loss. Nat Genet 2005;37:418-422.
47. Taylor MR, Slavov D, Gajewski A, et al. Thymopoietin (lamina-associated polypeptide 2) gene mutation associated with dilated cardiomyopathy. Hum Mutat 2005;26:566-574. (Pubitemid 41780479)
48. Li D, Parks SB, Kushner JD, et al. Mutations of presenilin genes in dilated cardiomyopathy and heart failure. Am J Hum Genet 2006;79:1030-1039.
49. Inagaki N, Hayashi T, Arimura T, et al. Alpha B-crystallin mutation in dilated cardiomyopathy. Biochem Biophys Res Commun 2006;342:379-386.
50. Arola AM, Sanchez X, Murphy RT, et al. Mutations in PDLIM3 and MYOZ1 encoding myocyte Z line proteins are infrequently found in idiopathic dilated cardiomyopathy. Mol Genet Metab 2007;90:435-440.
51. Duboscq-Bidot L, Xu P, Charron P, et al. Mutations in the Z-band protein myopalladin gene and idiopathic dilated cardiomyopathy. Cardiovasc Res 2008;77:118-125.
52. Knoll R, Postel R, Wang J, et al. Laminin-alpha4 and integrin-linked kinase mutations cause human cardiomyopathy via simultaneous defects in car-diomyocytes and endothelial cells. Circulation 2007;116:515-525.
53. Duboscq-Bidot L, Charron P, Ruppert V, et al. Mutations in the ANKRD1 gene encoding CARP are responsible for human dilated cardiomyopathy. Eur Heart J 2009;30:2128-2136.
54. Li D, Morales A, Gonzalez Quintana J, et al. Identification of novel mutations In RBM20 in patients with dilated cardiomyopathy. Clin Trans Sci 2010;3:90-97.
55. Brauch KM, Karst ML, Herron KJ, et al. Mutations in ribonucleic acid binding protein gene cause familial dilated cardiomyopathy. J Am Coll Cardiol 2009;54:930-941.
56. Parks SB, Kushner JD, Nauman D, et al. Lamin A/C mutation analysis in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Am Heart J 2008;156:161-169.
57. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999;341:1715-1724.
58. Brodsky G, Muntoni F, Miocic S, et al. Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. Circulation 2000;101:473-476.
59. Becane HM, Bonne G, Varnous S, et al. High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation. Pacing Clin Electrophysiol 2000;23:1661-1666.
60. Jakobs PM, Hanson E, Crispell KA, et al. Novel lamin A/C mutations in two families with dilated cardiomyopathy and conduction system disease. J Card Fail 2001;7:249-256.
61. Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002;39:981-990.
62. Hershberger RE, Hanson E, Jakobs PM, et al. A novel lamin A/C mutation in a family with dilated cardiomyopathy, prominent conduction system disease, and need for permanent pacemaker implantation. Am Heart J 2002;144:1081-1086.
63. Taylor MR, Fain PR, Sinagra G, et al. Natural history of dilated cardio-myopathy due to lamin A/C gene mutations. J Am Coll Cardiol 2003;41: 771-780.
64. Sebillon P, Bouchier C, Bidot LD, et al. Expanding the phenotype of LMNA mutations in dilated cardiomyopathy and functional consequences of these mutations. J Med Genet 2003;40:560-567.
65. MacLeod HM, Culley MR, Huber JM, McNally EM. Lamin A/C truncation in dilated cardiomyopathy with conduction disease. BMC Med Genet 2003;4:4.
66. Sylvius N, Bilinska ZT, Veinot JP, et al. In vivo and in vitro examination of the functional significances of novel lamin gene mutations in heart failure patients. J Med Genet 2005;42:639-647.
67. Pethig K, Genschel J, Peters T, et al. LMNA mutations in cardiac transplant recipients. Cardiology 2005;103:57-62.
68. Karkkainen S, Reissell E, Helio T, et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy. Heart 2006;92:524-526.
69. McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004;110:2163-2167.
70. Olson TM, Michels VV, Ballew JD, et al. Sodium channel mutations and susceptibility to heart failure and atrial fibrillation. JAMA 2005;293:447-454.
71. Hershberger RE, Kushner JK, Parks SP. Dilated cardiomyopathy overview. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online), 2007. July 10, 2008; initial posting, July 27, 2007. Available at: http://www.genetests.org. Accessed August 16, 2010.
72. Towbin JA, Hejtmancik JF, Brink P, et al. X-linked dilated cardiomyopathy. Molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 1993;87:1854-1865.
73. Muntoni F, Cau M, Ganau A, et al. Brief report: deletion of the dystrophin muscle-promoter region associated with x-linked dilated cardiomyopathy. N Engl J Med 1993;329:921-925.
74. D'Adamo P, Fassone L, Gedeon A, et al. The x-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet 1997;61:862-867.
75. Bione S, D'Adamo P, Maestrini E, et al. A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nat Genet 1996;12:385-389.
76. Codd MB, Sugrue DD, Gersh BJ, Melton LJ. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy: a population-based study in Olmsted, County, Minnesota, 1975-1984. Circulation 1989;80:564-572.
77. Maron BJ, Gardin JM, Flack JM, et al. Prevalence of hypertrophic cardio-myopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995;92:785-789.
78. Henry W, Gardin J, Ware J. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1980;62:1054-1061.
79. Vasan R, Larson M, Levy D, Evans J, Benjamin E. Distribution and categorization of echocardiographic measurements in relation to reference limits. The Framingham Heart Study: formulation of a height-and sex-specific classification and its prospective validation. Circulation 1997;96:1863-1873.
80. Hershberger RE, Ni H, Crispell KA. Familial dilated cardiomyopathy: echocardiographic diagnostic criteria for classification of family members as affected. J Card Fail 1999;51:203-212.
81. Kushner JD, Nauman D, Burgess D, et al. Clinical characteristics of 304 kindreds evaluated for familial dilated cardiomyopathy. J Card Fail 2006;12:422-429.
82. Baig MK, Goldman JH, Caforio AP, et al. Familial dilated cardiomyopa-thy: cardiac abnormalities are common in asymptomatic relatives and may represent early disease. J Am Coll Cardiol 1998;31:195-201.
83. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008;295:H1234-H1242.
84. Hanson E, Hershberger RE. Genetic counseling and screening issues in familial dilated cardiomyopathy. J Genet Counseling 2001;10:397-415.
85. GeneReviews at GeneTests. Medical Genetics Information Resource. GeneTests/GeneClinics [cited 2008 September 12, 2009]. Available at: http://www.genetests.org. Accessed August 16 2010.
86. Morales A, Painter T, Li R, et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010;121:2176-2182.
87. Elkayam U, Akhter MW, Singh H, et al. Pregnancy-associated cardiomy-opathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005;111:2050-2055.
88. Demakis JG, Rahimtoola SH, Sutton GC, et al. Natural course of peripar-tum cardiomyopathy. Circulation 1971;44:1053-1061.
89. Hershberger RE, Cowan J, Morales A. LMNA-related dilated cardiomyopathy. GeneTests/GeneClinics 2008, 2008. Available at: http://www.genetests.org. Accessed August 16, 2010.
90. Santorelli FM, Mak SC, El-Schahawi M, et al. Maternally inherited cardio-myopathy and hearing loss associated with a novel mutation in the mitochon-drial tRNA(Lys) gene (G8363A). Am J Hum Genet 1996;58:933-939.
91. Li YY, Maisch B, Rose ML, Hengstenberg C. Point mutations in mito-chondrial DNA of patients with dilated cardiomyopathy. J Mol Cell Car-diol 1997;29:2699-2709.
92. Arbustini E, Diegoli M, Fasani R, et al. Mitochondrial DNA mutations and mitochondrial abnormalities in dilated cardiomyopathy. Am J Pathol 1998; 153:1501-1510.
93. Santorelli FM, Tanji K, Manta P, et al. Maternally inherited cardiomyop-athy: an atypical presentation of the mtDNA 12S rRNA gene A1555G mutation. Am J Hum Genet 1999;64:295-300.
94. Marin-Garcia J, Goldenthal MJ, Ananthakrishnan R, Pierpont ME. The complete sequence of mtDNA genes in idiopathic dilated cardiomyopathy shows novel missense and tRNA mutations. J Card Fail 2000;6:321-329.
95. Mahjoub S, Sternberg D, Boussaada R, et al. A novel mitochondrial DNA tRNAIle (m. 4322dupC) mutation associated with idiopathic dilated car-diomyopathy. Diagn Mol Pathol 2007;16:238-242.
96. Michels VV, Moll PP, Miller FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyop-athy. N Engl J Med 1992;326:77-82.
97. McKenna C, Codd M, McCann H, Sugrue D. Idiopathic dilated cardiomy-opathy: familial prevalence and HLA distribution. Heart 1997;77:549-552.
98. Grünig E, Tasman JA, Kücherer H, et al. Frequency and phenotypes of familial dilated cardiomyopathy. J Am Coll Cardiol 1998;31:186-194.
99. Mestroni L, Rocco C, Gregori D, et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. J Am Coll Cardiol 1999;34:181-190.
100. Morales A, Cowan J, Dagua J, Hershberger RE. Family history: an essential tool for cardiovascular genetic medicine. Congest Heart Fail 2008;14:37-45.
101. Hershberger R. Familial dilated cardiomyopathy. Prog Pediatr Cardiol 2005;20:161-168.
102. Richard P, Charron P, Carrier L, et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003;107:2227-2232.
103. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc 2005;80: 739-744.
104. Sen-Chowdhry S, Syrris P, McKenna WJ. Role of genetic analysis in the management of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy. J Am Coll Cardiol 2007;50:1813-1821.
105. McNally E, MacLeod H, Dellefave L. Arrhythmogenic right ventricular dysplasia/cardiomyopathy, autosomal dominant. In: GeneReviews at GeneTests: Medical Genetics Information Resource (database online), 2008; initial posting, 2005. Available at: http://www.genetests.org.
106. Sen-Chowdhry S, Syrris P, Prasad SK, et al. Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity. J Am Coll Cardiol 2008;52:2175-2187.
107. Sen-Chowdhry S, Morgan RD, Chambers JC, McKenna WJ. Arrhythmo-genic cardiomyopathy: etiology, diagnosis, and treatment. Annu Rev Med 2010;61:233-253.
108. Hershberger R, Pinto J, Parks S, et al. Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomy-opathy. Circ Cardiovasc Genet 2009;2:306-313.
109. Gupta P, Bilinska ZT, Sylvius N, et al. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption. Basic Res Cardiol 2010;105:365-377.
110. Richard P, Villard E, Charron P, Isnard R. The genetic bases of cardiomy-opathies. J Am Coll Cardiol 2006;48(suppl A):A79-A89.
111. Bowles NE, Bowles KR, Towbin JA. The "final common pathway" hypothesis and inherited cardiovascular disease. The role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000;25:168-175.
112. Worman HJ, Courvalin JC. How do mutations in lamins A and C cause disease? J Clin Invest 2004;113:349-351.
113. Menon S, Michels V, Pellikka P, et al. Cardiac troponin T mutation in familial cardiomyopathy with variable remodeling and restrictive physiology. Clin Genet 2008;74:445-454.
114. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005;112:e154-e235.
115. Hunt SA, Abraham WT, Chin MH, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:e1-e90.
116. Heart Failure Society Of America. Executive summary: HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 2006;12:10-38.
117. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:685-691.
118. Karkkainen S, Peuhkurinen K. Genetics of dilated cardiomyopathy. Ann Med 2007;39:91-107.
119. Rampersaud E, Kinnamon D, Hamilton K, et al. Common susceptibility variants examined for association with dilated cardiomyopathy. Ann Hum Genet 2010;74:110-116.
120. Badano JL, Katsanis N. Beyond Mendel: an evolving view of human genetic disease transmission. Nat Rev Genet 2002;3:779-789.
121. Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat Genet 2008;40:695-701.
122. Ingles J, Doolan A, Chiu C, et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling. J Med Genet 2005;42:e59.
123. Girolami F, Ho CY, Semsarian C, et al. Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations. J Am Coll Cardiol 2010;55:1444-1453.
124. Schwartz PJ, Priori SG, Napolitano C. How really rare are rare diseases?: the intriguing case of independent compound mutations in the long QT syndrome. J Cardiovasc Electrophysiol 2003;14:1120-1121.
125. Westenskow P, Splawski I, Timothy KW, Keating MT, Sanguinetti MC. Compound mutations: a common cause of severe long-QT syndrome. Circulation 2004;109:1834-1841.
126. Sen-Chowdhry S, Syrris P, Ward D, et al. Clinical and genetic characterization of families with arrhythmogenic right ventricular dysplasia/cardio-myopathy provides novel insights into patterns of disease expression. Circulation 2007;115:1710-1720.
127. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet 2007;80:727-739.
128. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 2009;19:212-219.
129. Ng SB, Turner EH, Robertson PD, et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009;461:272-276.
130. Ng SB, Buckingham KJ, Lee C, et al. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet 2010;42:30-35.
131. Cowan J, Li D, Gonzalez Quintana J, Morales A, Hershberger RE. Morphological analysis of 13 LMNA variants identified in a cohort of 324 unrelated patients with idiopathic or familial dilated cardiomyopathy. Circ Cardiovasc Genet 2010;3:6-14.